Trials / Unknown
UnknownNCT05648747
Pelvic Inflammatory Disease in COVID-19 Era
Factors Associated With an Unfavorable Clinical Course in Hospitalized Patients With Pelvic Inflammatory Disease in Post Covid 19 Era: a Multicentric Retrospective Cohort Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Università degli Studi di Ferrara · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this retrospective cohort study is to to scrutinize the impact of coronavirus disease 2019 (COVID-19) on incidence, demography and patient characteristics in Pelvic Inflammatory Disease comparing with the equal time duration, before and after lockdown was initiated in the country. The main aim of this study was to compare the demographic and clinical parameters between two cohorts before the onset of lockdown and within the pandemic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | impact of COVID-19 on Health-Seeking Behaviors | The impact of the coronavirus disease 2019 (COVID-19) pandemic on medical services is overwhelming due to limited medical resources. During its initial surge in 2020, Italy's government rapidly established diverse public actions, which helped maintain the medical supply. However, whether the fear of being infected with COVID-19 interfered with health-seeking behavior (HSB) remains unclear. Therefore, this study aimed to elucidate whether pelvic inflammatory disease rates were affected by the COVID-19 pandemic. |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2024-01-01
- Completion
- 2024-01-30
- First posted
- 2022-12-13
- Last updated
- 2022-12-13
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05648747. Inclusion in this directory is not an endorsement.